ObsEva (NASDAQ:OBSV) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the stock.

ObsEva Price Performance

Shares of OBSV opened at $0.01 on Friday. The company has a market capitalization of $389,855.00, a P/E ratio of -0.01 and a beta of 0.68. ObsEva has a one year low of $0.08 and a one year high of $2.14. The business’s 50 day simple moving average is $0.02 and its 200-day simple moving average is $0.04.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.